Friday, March 02, 2018 9:22:57 PM
This stock still has dangerous upside.
They are in the hottest biotech field right now, antibodies for cancer and other diseases, including infections.
antibiotics are hard to come by and have narrow usage.
true, stock looks expensive, but they only have 8 million O/S!
Recent XOMA News
- XOMA Royalty Announces CFO Transition • GlobeNewswire Inc. • 01/12/2026 12:30:00 PM
- XOMA Royalty and Takeda Execute Strategic Royalty Sharing Transaction and Amend Existing Agreement for Mezagitamab • GlobeNewswire Inc. • 12/30/2025 12:30:00 PM
- XOMA Royalty Declares Quarterly Preferred Stock Dividends • GlobeNewswire Inc. • 12/22/2025 12:30:00 PM
- XOMA Royalty Enters into Agreement to Acquire Generation Bio • GlobeNewswire Inc. • 12/15/2025 10:00:00 PM
- XOMA Royalty Announces Closing of Transaction to Acquire Mural Oncology plc • GlobeNewswire Inc. • 12/05/2025 02:00:00 PM
- Mural Oncology Announces Effectiveness of Scheme of Arrangement and Completion of Acquisition • GlobeNewswire Inc. • 12/05/2025 12:45:00 PM
- Mural Oncology Announces Final Cash Consideration Payable on Closing of Acquisition by XOMA Royalty • GlobeNewswire Inc. • 11/26/2025 02:00:00 PM
- XOMA Royalty Announces Closing of Transactions to Acquire LAVA Therapeutics N.V. • GlobeNewswire Inc. • 11/21/2025 12:45:00 PM
- XOMA Royalty Reports Third Quarter and Year to Date 2025 Financial Results and Highlights Recent Business Achievements • GlobeNewswire Inc. • 11/12/2025 12:30:00 PM
- LAVA Therapeutics N.V. Shareholders are Reminded to Tender Shares for XOMA Royalty Transaction Before November 12, 2025 Deadline • GlobeNewswire Inc. • 11/10/2025 09:09:25 PM
- Mural Oncology Announces that Mural Shareholders Approve the Proposed Acquisition by XRA 5 Corp., a Wholly Owned Subsidiary of XOMA Royalty • GlobeNewswire Inc. • 10/24/2025 08:25:31 PM
- XOMA Royalty and LAVA Therapeutics Announce Amendment to Purchase Agreement • GlobeNewswire Inc. • 10/17/2025 03:45:00 PM
- XOMA Royalty Extends Tender Offer to Acquire LAVA Therapeutics N.V. • GlobeNewswire Inc. • 10/02/2025 08:43:26 PM
- ESSA Pharma Inc. Amends Agreement with XenoTherapeutics • PR Newswire (US) • 09/24/2025 10:00:00 AM
- ESSA Pharma Inc. Amends Agreement with XenoTherapeutics • PR Newswire (Canada) • 09/24/2025 10:00:00 AM
- XOMA Royalty Declares Quarterly Preferred Stock Dividends • GlobeNewswire Inc. • 09/22/2025 11:30:00 AM
- XOMA Royalty Announces Closing of Tender Offer for HilleVax, Inc. • GlobeNewswire Inc. • 09/17/2025 01:00:00 PM
- XOMA Royalty to Present at H.C. Wainwright 27th Annual Global Investment Conference • GlobeNewswire Inc. • 09/03/2025 11:30:00 AM
- Mural Oncology Announces Entry into Agreement to be Acquired by XRA 5 Corp., a wholly owned subsidiary of XOMA Royalty for between $2.035 and $2.24 in Cash per Share • GlobeNewswire Inc. • 08/20/2025 12:49:14 PM
- Mural Oncology Announces Entry into Agreement to be Acquired by XRA 5 Corp., a wholly owned subsidiary of XOMA Royalty for between $2.035 and $2.24 in Cash per Share • GlobeNewswire Inc. • 08/20/2025 12:30:00 PM
- XOMA Royalty Reports Second Quarter and Year to Date 2025 Financial Results and Highlights Recent Business Achievements • GlobeNewswire Inc. • 08/13/2025 11:30:00 AM
- XOMA Royalty Announces Closing of Tender Offer for Turnstone Biologics • GlobeNewswire Inc. • 08/11/2025 01:00:00 PM
- Rowley Law PLLC is Investigating Proposed Acquisition of HilleVax, Inc. • PR Newswire (US) • 08/05/2025 10:01:00 PM
- Hillevax Shares Gain on Acquisition Deal with XOMA Royalty • IH Market News • 08/04/2025 03:00:59 PM
- LAVA Therapeutics Shares Climb on Buyout Deal with XOMA Royalty • IH Market News • 08/04/2025 02:59:11 PM
LaFleur Minerals Reports Assay Results Highlighting 2.05 g/t Au over 158.25 metres, Confirming Strong Gold Continuity at Swanson Gold Project • LFLRF • Feb 5, 2026 5:29 AM
DRCR Begins Rollout of New Business Model • DRCR • Feb 4, 2026 12:42 PM
BIO-PATH HOLDINGS ANNOUNCES "BPTH 2.0" STRATEGIC PIVOT ON WORLD CANCER DAY; ENGAGES LEGAL COUNSEL FOR REGULATION A OFFERING • BPTH • Feb 4, 2026 10:00 AM
Branded Legacy, Inc. (OTC: BLEG) Successfully Negotiates Retirement of Four Additional Convertible Notes, Preventing Potential Dilution of Hundreds of Millions of Shares • BLEG • Feb 4, 2026 9:07 AM
ConnectM Subsidiary Signs Definitive Agreement with Alpex Solar to Execute Solar Deployments Worth an Initial ~$16.5M • CNTM • Feb 4, 2026 9:05 AM
The Hidden Revenue Drain in Hospitality-and How AI Robotics Is Finally Closing the Gap • NGTF • Feb 4, 2026 9:00 AM
